Bundamedik Tbk vs Trimuda Nuansa Citra Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Trimuda Nuansa Citra Tbk. trades at Rp134 (market cap 57.76B, 4.46M 24h volume). The key difference: Bundamedik Tbk is far larger — about 26.1× Trimuda Nuansa Citra Tbk.'s market cap, and Trimuda Nuansa Citra Tbk. is more actively traded (4.46M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | TNCA | |
|---|---|---|
Market Cap | 1.51T | 57.76B |
Volume | 536.7K | 4.46M |
Lot | 5.37K | 44.55K |
Turnover | 93.41M | 588.72M |
Average Price | 174.05 | 132.15 |
Value | 93.41M | 588.72M |
Indicative Equilibrium Price | 176 | 134 |
Indicative Equilibrium Volume | 100 | 183 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.
Read more on TNCA →